Medios Technologies
AcquiredAI retinal screening for early eye care.
What it does
Medios Technologies applied deep learning to retinal images, enabling primary care clinicians to detect diabetic retinopathy in seconds. Clinics integrated its AI screening tool into routine exams—expanding access to early diagnosis and preventing vision loss where specialists are scarce. Medios Technologies exited to Remidio in 2019.